metallic taste in her mouth; Tested positive for COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID) and DYSGEUSIA (metallic taste in her mouth) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-May-2022, the patient experienced DYSGEUSIA (metallic taste in her mouth). In May 2022, the patient experienced COVID-19 (Tested positive for COVID). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) (oral) ongoing from 11-May-2022 for COVID-19, at a dose of Take 2 of the nirmatrelvir and one of the ritonavir twice a day by mouth. At the time of the report, COVID-19 (Tested positive for COVID) and DYSGEUSIA (metallic taste in her mouth) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In May 2022, SARS-CoV-2 test: positive (Positive) Tested positive for COVID.         Ethnicity of the patient was reported. The patient reported that she was not on any medication, period; and had not taken anything else different. Reason for no lot number of Paxlovid was mentioned as pharmacy sticker over the top of the box. The patient reported that the metallic taste started after the first dose of Paxlovid.  No treatment information for the event taste metallic was mentioned.  Company comment- This spontaneous case concerns a 71-year-old female patient with no reported medical history, who experienced unexpected, non-serious adverse event of special interest Covid-19 (with a positive SARS-CoV-2 test), along with a non-serious event of Dysgeusia. The patient was vaccinated with 3 doses of mRNA-1273 on unknown dates. The events occurred at an unknown time with regards to the mRNA-1273 vaccination. After the patient tested positive for Covid-19, she was prescribed with Paxlovid. After taking Paxlovid, the patient complained of a metallic taste. No further information was provided. The outcome of the events was reported as unknown. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 71-year-old female patient with no reported medical history, who experienced unexpected, non-serious adverse event of special interest Covid-19 (with a positive SARS-CoV-2 test), along with a non-serious event of Dysgeusia. The patient was vaccinated with 3 doses of mRNA-1273 on unknown dates. The events occurred at an unknown time with regards to the mRNA-1273 vaccination. After the patient tested positive for Covid-19, she was prescribed with Paxlovid. After taking Paxlovid, the patient complained of a metallic taste. No further information was provided. The outcome of the events was reported as unknown. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.